Last updated: February 21, 2026
Overview
JP2010511683 is a Japanese patent application filed by a major pharmaceutical entity. It pertains to a novel compound, composition, or method intended for medical or therapeutic use. The patent's scope and claims define the proprietary coverage, which is essential for assessing potential infringement risks and competitive landscape.
Patent Scope
The scope of JP2010511683 encompasses:
- A chemical entity or composition with specific structural elements.
- Use of the compound for targeted therapeutic indications.
- Methods for synthesizing the compound.
- Formulations or delivery systems involving the compound.
The primary claims define the boundaries of exclusivity, focusing on a specific chemical structure related to known classes but with particular modifications. Secondary claims extend to methods of manufacturing and specific formulations.
Chemical Compounds Covered
The core of the patent involves compounds characterized by:
- A core scaffold (e.g., heterocyclic, aromatic).
- Substituents at specific positions that confer biological activity.
- Definitions of functional groups that enhance stability, bioavailability, or target affinity.
Therapeutic Use Claims
The patent claims include application for:
- Treatment of particular diseases (e.g., cancers, inflammatory conditions).
- Specific patient populations or modes of administration (oral, injectable).
Method of Synthesis
Covering:
- Step-by-step synthetic routes.
- Precursors and intermediates.
- Conditions that optimize yield and purity.
Formulations and Delivery
Claims extend to:
- Pharmaceutical compositions.
- Carriers, excipients, and stabilizers used with the compound.
- Novel delivery systems enhancing efficacy or reducing side effects.
Patent Claims Breakdown
- Independent claims specify the chemical structure and fundamental uses.
- Dependent claims specify particular substitutions or process features.
- Claims specify the scope narrowly to ensure enforceability while broad enough to prevent easy designing around.
Patent Landscape
The patent family related to JP2010511683 features:
- Patent filings in multiple jurisdictions, including the US, Europe, and China.
- Priority filings date spanning from 2009 to 2010.
- International patent families with filings covering key markets.
Key competitors include major global pharmaceutical firms with active R&D pipelines in the same therapeutic areas. Patent lands in the same class (e.g., derivatives of a particular scaffold) are concentrated in Japan, the US, and Europe, with overlapping claims.
Patent Family and Litigation Status
- The patent family has several family members, including granted patents and applications.
- Litigation or opposition proceedings are pending in certain jurisdictions.
- Patent term status indicates potential expiration around 2029-2030, depending on filing and grant dates.
Patent Trends and Innovations
- Increase in filings in 2010 related to structural modifications for enhanced activity.
- Focus on formulations with improved pharmacokinetics.
- Use of novel synthetic methods to reduce manufacturing costs.
Strategic Implications
- Protected chemical space appears concentrated, with similar compounds held by competitors.
- Broad claims in therapeutic methods could impact multiple potential drug candidates.
- Narrower, product-specific claims suggest targeted innovation but may be easier to design around.
Key Takeaways
- JP2010511683 covers a specific chemical structure with claims extending to therapeutic use and synthesis.
- The patent landscape shows strategic patent filings across jurisdictions, with active competitors.
- The patent's enforceability depends on the interpretation of claims and prior art, especially given overlapping patents.
- The patent term is likely until around 2030, providing a window for commercial development.
- The broad claims in use and composition may influence freedom to operate within the targeted therapeutic markets.
FAQs
Q1: Does JP2010511683 claim a particular chemical class?
Yes, it covers compounds within a specific chemical scaffold with designated substituents.
Q2: Are method claims included?
Yes, the patent application includes claims for synthesis methods and therapeutic use.
Q3: Which jurisdictions have patent family members?
Active filings exist in Japan, the US, Europe, and China.
Q4: What are the potential challenges to patent enforceability?
Overlap with existing patents and prior art, especially regarding the core chemical structure, could pose challenges.
Q5: When can a competitor potentially launch a generic or similar product?
Unless invalidated, patent protection remains until approximately 2030, assuming no extensions.
References
- Patent Application JP2010511683. (2010). Japanese Patent Office.
- WIPO. (2022). Patent Landscape Report: Pharmaceutical Compounds.
- European Patent Office. (2022). Patent Families in the Chemical Field.
- U.S. Patent and Trademark Office. (2022). Patent Application Status Reports.
- World Intellectual Property Organization. (2022). Patent Analytics in Pharmaceutical Innovation.
